2 results match your criteria: "Unisabana Center of Translational Science[Affiliation]"

Article Synopsis
  • Patients with COVID-19 on ventilators have a higher risk of developing ventilator-associated pneumonia (VAP), which can lead to increased healthcare costs and worse outcomes.* -
  • This study analyzed the lung microbiome and immune responses in mechanically ventilated COVID-19 patients to understand the mechanisms leading to VAP, comparing samples taken shortly after intubation and 72 hours later.* -
  • Results showed differences in the microbiome related to VAP, along with higher viral loads and unique metabolic changes in patients who developed VAP, highlighting the complex interactions between microbiota, viral response, and inflammation.*
View Article and Find Full Text PDF

Background: Early and adequate antibiotic treatment is the cornerstone of improving clinical outcomes in patients with bloodstream infections (BSI). Delays in appropriate antimicrobial therapy have catastrophic consequences for patients with BSI. Microbiological characterization of multi-drug resistant pathogens (MDRP) allows clinicians to provide appropriate treatments.

View Article and Find Full Text PDF